RevBio, Inc.

RevBio, Inc. is a biotechnology startup founded in 2014, with the slogan "Transforming Bone Repair." The company's flagship product, Tetranite®, is a groundbreaking biocompatible bone adhesive inspired by the sandcastle worm. Tetranite® boasts properties that address the long-standing challenges in bone repair, including wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability. The adhesive has shown promise in fixing bone fractures, defects, and securing implant devices, as evidenced by multiple animal studies. The product has garnered attention from investors, with the National Institutes of Health providing a $2.00M grant investment in October 2023. With its innovative approach to bone repair, RevBio, Inc. is poised to make a significant impact on the biotechnology, healthcare, and medical devices industries from its headquarters in the United States.